Work

Hepatic safety analysis of trabectedin: results of a pharmacokinetic study with trabectedin in patients with hepatic impairment and experience from a phase 3 clinical trial

Year: 2017

Type: article

Source: Investigational New Drugs

DOI: 10.1007/s10637-017-0546-9

Authors: Emiliano Calvo, Analia Azaro, Jordi Rodon, Luc Dirix, Manon Huizing, Francis Mark Senecal, Patricia LoRusso, Lorrin Yee, Italo Poggesi, Jan de Jong, Spyros Triantos, Youn C. Park, Roland E. Knoblauch, Trilok V. Parekh, George D. Demetri, Margaret von Mehren

Institutions: Universitat Autònoma de Barcelona, Vall d'Hebron Hospital Universitari, GZA Ziekenhuizen Campus Sint-Augustinus, GZA Ziekenhuizen, Antwerp University Hospital, Wayne State University, Yale Cancer Center, Yale University, The Barbara Ann Karmanos Cancer Institute, Northwest Medical Specialties, Janssen (Italy), Janssen Research & Development (United States), Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center, Fox Chase Cancer Center

Language: English

Topic: Sarcoma Diagnosis and Treatment

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Cancer Institute, Janssen Research and Development

Award: G156276794

OpenAlex ID: W2770518644

FWCI: 0.607

Cites: 22

Cited by: 7

Related to: 10